Authors: THOR AD BERRY DA BUDMAN DR MUSS HB KUTE T HENDERSON IC BARCOS M CIRRINCIONE C EDGERTON S ALLRED C NORTON L LIU ET

Citation: Ad. Thor et al., ERBB-2, P53, AND EFFICACY OF ADJUVANT THERAPY IN LYMPH NODE-POSITIVE BREAST-CANCER, Journal of the National Cancer Institute, 90(18), 1998, pp. 1346-1360

Authors: MAKRIS A POWLES TJ ALLRED C DOWSETT M

Citation: A. Makris et al., P53 MUTATION AND CHEMOSENSITIVITY IN BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 668-668

Authors: KHANSUR T ALLRED C LITTLE D ANAND V

Citation: T. Khansur et al., CISPLATIN AND 5-FLUOROURACIL FOR METASTATIC SQUAMOUS-CELL CARCINOMA FROM UNKNOWN PRIMARY, Cancer investigation, 13(3), 1995, pp. 263-266

Authors: MAKRIS A POWLES TJ DOWSETT M ALLRED C

Citation: A. Makris et al., P53 PROTEIN OVEREXPRESSION AND CHEMOSENSITIVITY IN BREAST-CANCER, Lancet, 345(8958), 1995, pp. 1181-1182

Authors: KHANSUR T ALLRED C TAVASSOLI M

Citation: T. Khansur et al., 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C IN ADENOCARCINOMA OF THE ESOPHAGUS OR GASTROESOPHAGEAL JUNCTION TUMORS, American journal of clinical oncology, 17(6), 1994, pp. 506-508